Kentucky NAS Reporting and Privacy: How NICUs Should Document Maternal Opioid Exposure

NAS Reporting Requirement in Kentucky

In Kentucky, Neonatal Abstinence Syndrome (NAS) is monitored through statewide public health surveillance led by the Kentucky Department for Public Health. Hospitals and NICUs report cases using the NAS Reportable Disease Form so the state can track trends, improve care, and allocate resources. Accurate maternal opioid exposure documentation is essential to the completeness of each report.

Reporting is triggered when an infant receives a Neonatal Abstinence Syndrome diagnosis based on clinical signs consistent with withdrawal after in‑utero exposure to opioids, with or without toxicology confirmation. Submissions should occur as soon as practical per state timelines and facility policy, with updates added at discharge or when key clinical details change.

• Who reports: birthing hospitals, NICUs, and other facilities diagnosing NAS.
• What to report: infant demographics, clinical criteria, treatment, discharge outcomes, and maternal opioid exposure details.
• Where to report: the NAS Statewide Surveillance Registry via the NAS Reportable Disease Form.

NAS Statewide Surveillance Registry Use

Step-by-step workflow

• Access: Sign in to the secure NAS Statewide Surveillance Registry with your assigned credentials; use only role-based accounts.
• Start a case: Create a new record and enter infant identifiers, birth facility, dates of birth/admission, and medical record number.
• Clinical details: Document the Neonatal Abstinence Syndrome diagnosis date, scoring approach (e.g., Finnegan or Eat, Sleep, Console), symptoms observed, and pharmacologic or non-pharmacologic treatments.
• Maternal exposure: Add Maternal Opioid Exposure Documentation, including substance type (e.g., prescribed opioids, methadone, buprenorphine, illicit opioids), timing, and source of information.
• Toxicology: Record screen and confirmatory results for infant and maternal specimens, specifying specimen type (urine, meconium, cord tissue) and test method if known.
• Outcome data: Complete discharge status, feeding plan, follow-up referrals (e.g., early intervention), and any readmission information.
• Finalize and update: Save, validate, submit, and return to update fields at discharge to maintain a complete longitudinal record.

Data quality essentials

• Use structured fields that mirror the NAS Reportable Disease Form to reduce free-text variability.
• Run duplicate checks by medical record number, date of birth, and case ID before submitting.
• Designate a secondary reviewer to confirm exposure, scoring, and treatment entries for high-risk or complex cases.

Confidentiality and Data Privacy Measures

NAS reporting to the Kentucky Department for Public Health occurs under public health authority and should follow the HIPAA “minimum necessary” standard. Limit submissions to fields required by the NAS Reportable Disease Form and avoid uploading extraneous notes that include unrelated sensitive information.

• Access control: Maintain role-based permissions, unique user logins, and audit trails within the registry and the EHR.
• Secure transmission: Enter data only through approved, encrypted channels; never send reportable data via unsecured email.
• De-identified Data Reporting: Use de-identified or aggregated data for analytics, internal dashboards, and external summaries when individual-level information is not required.
• 42 CFR Part 2 awareness: If maternal records originate from a federally assisted substance use disorder program, coordinate with compliance to ensure appropriate handling and disclosure pathways.
• Retention and governance: Follow facility and state retention schedules, and document who submitted, when, and what was updated for each case.

Maternal Substance Use Documentation Standards

What to capture

• Substance specifics: Opioid type (e.g., heroin, fentanyl, methadone, buprenorphine, prescribed opioids), pattern of use or treatment, and timing by trimester when known.
• Source and certainty: Identify whether information is from maternal history, prenatal records, prescription records, or toxicology; note uncertainty without speculation.
• Co-exposures: Benzodiazepines, gabapentin, stimulants, alcohol, and nicotine, as these influence presentation and management.
• Toxicology: Document specimen type, collection timing, screen versus confirmatory method, and qualitative results.

How to document

• Use NICU Clinical Documentation Standards and templates that map directly to registry fields and your EHR’s discrete data elements.
• Apply appropriate diagnostic codes (e.g., ICD-10-CM P96.1 and P04.14, per current coding guidance) and link them to the encounter with clear clinical rationale.
• Describe non-pharmacologic care (e.g., rooming-in, swaddling, low-stimulation environment) and any pharmacologic therapy with start/stop dates and weaning steps.
• Use person-first, non-stigmatizing language; avoid judgmental terms and maintain factual, objective tone.

NICU Best Practices for Documentation

• Standardize: Build an NAS documentation checklist and EHR flowsheet that mirror the NAS Reportable Disease Form and required registry fields.
• Capture in real time: Enter maternal exposure, scoring, and medication changes at the point of care to prevent omissions.
• Interdisciplinary workflow: Define roles for neonatology, nursing, pharmacy, case management, and social work, including who initiates and who finalizes the registry submission.
• Consistency: Use a single scoring approach unit-wide and provide quick-reference definitions to improve inter-rater reliability.
• Data validation: Require a peer review before submission for complex cases; reconcile registry case counts with EHR diagnosis and discharge data monthly.
• Education: Provide onboarding and annual refreshers on NAS documentation, privacy, and the NAS Statewide Surveillance Registry.

Compliance with State NAS Reporting Laws

• Policy alignment: Incorporate Kentucky NAS reporting requirements into facility policy, including triggers, timelines, and responsible roles.
• Submission proof: Retain submission confirmations, case IDs, and timestamps for audits; file these with a copy of the completed NAS Reportable Disease Form.
• Transfers: Establish a protocol with referring/receiving facilities to avoid duplicate submissions and to clarify who updates the case at discharge.
• Quality assurance: Conduct periodic audits to identify underreporting or data quality gaps and implement corrective action plans.
• Issue management: If an error is discovered, correct it promptly in the registry and document the remediation steps taken.

Supporting Infant Care through Accurate Reporting

High-quality, timely NAS reporting strengthens care at the bedside. Reliable data help NICUs evaluate non-pharmacologic bundles, refine treatment thresholds, and track feeding and length-of-stay outcomes by exposure pattern and co-exposures.

At the system level, accurate reporting informs the Kentucky Department for Public Health about regional needs, guiding prevention, family support, and follow-up services. It also enables safer care transitions by aligning clinical documentation with surveillance data.

Conclusion

By aligning Maternal Opioid Exposure Documentation with the NAS Statewide Surveillance Registry, using standardized NICU Clinical Documentation Standards, and protecting privacy through De-identified Data Reporting, your NICU can meet Kentucky requirements and improve infant outcomes. Clear roles, real-time entries, and routine audits keep reporting accurate and actionable. Consistency, compassion, and data discipline are the pillars of effective NAS reporting.

FAQs.

What data must be reported for NAS cases in Kentucky?

Typically, reports include infant demographics, birth and admission dates, Neonatal Abstinence Syndrome diagnosis details, scoring method and findings, treatments provided, discharge status, and follow-up referrals. Maternal fields include opioid type, timing, source of information, and co-exposures, along with relevant toxicology results. Reporter name, facility, and submission date are also captured.

How is maternal opioid exposure documented for NAS reporting?

Document exposure using structured fields that specify opioid type (e.g., methadone, buprenorphine, prescribed opioids, illicit opioids), timing by trimester when known, and data source (maternal history, prenatal record, toxicology). Note co-exposures and whether the mother is receiving medication for opioid use disorder. Record uncertainty transparently and avoid assumptions.

What privacy protections exist for NAS reporting data?

NAS data are submitted under public health authority with HIPAA’s minimum-necessary standard. Facilities should use secure, role-based access; encrypt data in transit; audit user activity; and rely on De-identified Data Reporting for analytics or dashboards. Coordinate with compliance when information may be subject to additional protections, such as 42 CFR Part 2.

How should NICUs comply with NAS reporting requirements?

Embed state requirements into policy; mirror registry fields in EHR templates; assign a reporting lead and backup; submit promptly at diagnosis and update at discharge; keep proof of submission; and reconcile registry cases against EHR diagnoses monthly. Provide ongoing staff training and correct identified errors quickly to maintain data integrity.